Literature DB >> 19538320

Mechanisms of tight junction dysregulation in the SAMP1/YitFc model of Crohn's disease-like ileitis.

Brian K Reuter1, Theresa T Pizarro.   

Abstract

To date, the precise etiology of inflammatory bowel disease (IBD) remains largely unknown; however, it is well accepted that IBD results from a dysregulated mucosal immune response to environmental factors in genetically susceptible hosts. The primary defect, in at least a subpopulation of IBD patients, may be due to abnormal intestinal epithelial barrier function. The SAMP1/YitFc (SAMP) mouse strain is a spontaneous model of IBD, closely resembling Crohn's disease for its histologic features and localization to the terminal ileum. Dysregulated epithelial barrier function that precedes histologic evidence of ileitis has been reported to be the primary defect in SAMP mice. Data suggest that barrier dysfunction occurs in the absence of commensal bacteria and is accompanied by aberrant expression of the tight junction proteins claudin-2 and occludin. Further investigation is needed to define the precise role of the intestinal epithelium, as well as the apical junctional complex and its associated proteins, in the pathogenesis of IBD in order to determine the etiology and aid in the development of novel treatment modalities for these devastating diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538320     DOI: 10.1111/j.1749-6632.2009.04035.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  19 in total

1.  Actin reorganization as the molecular basis for the regulation of apoptosis in gastrointestinal epithelial cells.

Authors:  Y Wang; S P George; K Srinivasan; S Patnaik; S Khurana
Journal:  Cell Death Differ       Date:  2012-03-16       Impact factor: 15.828

2.  Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology.

Authors:  Linda Chia-Hui Yu; Jin-Town Wang; Shu-Chen Wei; Yen-Hsuan Ni
Journal:  World J Gastrointest Pathophysiol       Date:  2012-02-15

Review 3.  The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease.

Authors:  Michel Neunlist; Laurianne Van Landeghem; Maxime M Mahé; Pascal Derkinderen; Stanislas Bruley des Varannes; Malvyne Rolli-Derkinderen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

4.  Immunopathogenesis of inflammatory bowel disease.

Authors:  Julien Matricon; Nicolas Barnich; Denis Ardid
Journal:  Self Nonself       Date:  2010-10

5.  Increase in the tight junction protein claudin-1 in intestinal inflammation.

Authors:  Lisa S Poritz; Leonard R Harris; Ashley A Kelly; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2011-07-12       Impact factor: 3.199

Review 6.  SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis.

Authors:  Theresa T Pizarro; Luca Pastorelli; Giorgos Bamias; Rekha R Garg; Brian K Reuter; Joseph R Mercado; Marcello Chieppa; Kristen O Arseneau; Klaus Ley; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2011-05-06       Impact factor: 5.325

7.  A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection.

Authors:  Anthony J Smith; Timothy W Schacker; Cavan S Reilly; Ashley T Haase
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

8.  Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation.

Authors:  Lily Nahidi; Steven T Leach; Daniel A Lemberg; Andrew S Day
Journal:  Dig Dis Sci       Date:  2013-09-19       Impact factor: 3.199

Review 9.  Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation.

Authors:  Holger K Eltzschig; Jesus Rivera-Nieves; Sean P Colgan
Journal:  Expert Opin Ther Targets       Date:  2009-11       Impact factor: 6.902

10.  Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism.

Authors:  Daniele Corridoni; Luca Pastorelli; Benedetta Mattioli; Silviu Locovei; Dai Ishikawa; Kristen O Arseneau; Marcello Chieppa; Fabio Cominelli; Theresa T Pizarro
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.